Skip to Main Content

Paper Details

Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
Nat Immunol
175
2022
BNT162b2, BNT162b2 mRNA, CD8, CD8 T cell, CD8 T cells, IFN, IFN-?, MDA5, Toll-like receptors 2, 3, 4, mice, natural killer cells, serum interferon, type I interferon
Author NameAffiliation
Chunfeng LiInstitute for Immunity, Stanford University
Prabhu S ArunachalamInstitute for Immunity, Stanford University
Madeleine K D ScottInstitute for Immunity, Stanford University
Madeleine K D ScottCenter for Biomedical Informatics, Stanford University School of Medicine
Florian WimmersInstitute for Immunity, Stanford University
Yupeng FengInstitute for Immunity, Stanford University
Julia Z AdamskaInstitute for Immunity, Stanford University
Erika V ValoreInstitute for Immunity, Stanford University
Wei LuoIndiana University School of Medicine
Purvesh KhatriInstitute for Immunity, Stanford University
Purvesh KhatriCenter for Biomedical Informatics, Stanford University School of Medicine
Purvesh KhatriInstitute for Immunity, Stanford University
Purvesh KhatriCenter for Biomedical Informatics, Stanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University
Bali PulendranStanford University School of Medicine
Bali PulendranStanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University
Bali PulendranStanford University School of Medicine
Bali PulendranStanford University School of Medicine
  • 1 - 19

Datasets